Performance analysis of Marker Therapeutics (MRKR)
Annual Return
Over the past 3 years, MRKR has had an average annual return of -42.27%, underperforming the benchmark SPY, which returned +19.63% annual.
Over the past 5 years, MRKR has had an average annual return of -43.75%, underperforming the benchmark SPY, which returned +12.73% annual.
Over the past 10 years, MRKR has had an average annual return of -30.86%, underperforming the benchmark SPY, which returned +15.04% annual.
Since Mar 25, 2014, MRKR has had an average annual return of -39.12%, underperforming the benchmark SPY, which returned +13.83% annual.
| 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| -15.38% | -50.94% | -44.21% | +106.52% | -71.78% | -34.54% | -49.70% | -48.11% | +41.54% | +1.05% | -46.08% | +114.38% |
| 2014 | |||||||||||
| -94.23% |
Monthly Return
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Annually Total |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | +3.85% | -7.41% | -12.00% | +13.64% | +8% | -7.41% | -12.00% | -15.38% | |||||
| 2025 | -39.62% | -18.75% | -19.23% | -4.76% | +35% | -3.70% | -7.69% | -33.33% | -6.25% | +13.33% | +23.53% | +23.81% | -50.94% |
| 2024 | -15.79% | -22.50% | +19.35% | -5.41% | -5.71% | +40.91% | -9.68% | -26.19% | -22.58% | +45.83% | -14.29% | -11.67% | -44.21% |
| 2023 | +4.35% | -22.92% | -67.57% | +16.67% | +121.43% | +70.97% | +64.15% | +11.49% | -19.59% | -47.44% | +14.63% | +102.13% | +106.52% |
| 2022 | -36.20% | -37.50% | +16.92% | -23.68% | -10.34% | +9.62% | -3.51% | -3.64% | +18.87% | +20.63% | -31.58% | -11.54% | -71.78% |
| 2021 | +32.53% | +26.06% | -7.45% | +14.29% | +13.64% | -4.20% | -25.05% | -5.29% | -14.71% | -12.76% | -19.76% | -19.70% | -34.54% |
| 2020 | -10.10% | -4.72% | -23.11% | +45.40% | -17.72% | -8.72% | -3.09% | -10.43% | -16.50% | -9.30% | +24.79% | -14.73% | -49.70% |
| 2019 | -4.72% | +17.60% | +6.08% | -20.02% | +6.28% | +41.18% | -41.81% | +12.12% | -1.13% | -24.83% | -13.03% | -13.76% | -48.11% |
| 2018 | -0.59% | -16.72% | +4.12% | -21.69% | +94.95% | +82.64% | -25.68% | +23.01% | +5% | -0.32% | -21.74% | -21.35% | +41.54% |
| 2017 | +7.65% | +7.94% | -0.52% | -6.36% | -7.20% | -0.45% | -16.34% | +0% | -7.35% | +0.39% | -7.90% | +41% | +1.05% |
Drawdown analysis of Marker Therapeutics (MRKR)
The maximum drawdown for the MRKR was -99.88%, occurring on Mar 31, 2023. This drawdown has not yet recovered.
The current MRKR drawdown is -99.78%.
Since Mar 25, 2014 MRKR has experienced the following drawdowns:
- 50% or more: 1 time
- 40% or more: 1 time
- 30% or more: 1 time
- 20% or more: 1 time
- 10% or more: 1 time
| Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -99.88% | Mar 25, 2014 | 2271 | Mar 31, 2023 | Ongoing | Ongoing | Ongoing |